State of the Science
Psychotic Disorders
Peter Weiden, MD
Clinical Professor of Psychiatry (pending voluntary appointment)
Department of Psychiatry & Behavioral Health
Renaissance School of Medicine at Stony Brook University
Schizophrenia is a complex and heterogeneous disorder that affects approximately 1% of the population worldwide. Despite significant progress in the field, many questions remain about the underlying mechanisms of the disorder and the most effective interventions. This session will provide an overview of the latest research findings, including advances in genetic and neurobiological research, new diagnostic approaches, and emerging treatments.
By the end of this session, participants will have gained a deeper understanding of the current state of knowledge regarding schizophrenia, as well as the implications of these findings for clinical practice, policy, and future research.